Taken together, our data demonstrated that modulation of ROS by procyanidin provided a potential method for colitis treatment, downregulating the expression of MMP9, the activation of NF-κB signaling, and the NLRP3 inflammasome at the same time. Here, NLRP3 is linked to colitis.